pat mccutcheon champignon

| Source: VANCOUVER, British Columbia, May 06, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointment of Pat McCutcheon … Pat McCutcheon, director of AltMed, stated: “Together with Champignon’s existing novel ketamine delivery platforms, associated patents/IP and now … 6, 2020, 09:05 AM. Mr. Fish’s skillset will assist the Company in accelerating its North American new clinical entity roll-out. Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (“MediPharm”) (LABS.TO). ... Champignon Brands Inc. 05/2020–PRESENT. South of the border, the company’s U.S. OTC Markets listed SHRMF stock finished the day down 2.74% at $0.59 per share. Overseas on the Frankfurt Stock Exchange, Champignon’s German listed shares traded down 2.53% to close the … For more information, visit the Company’s website at: https://champignonbrands.com/. Champignon also reports that it has appointed Matthew Fish, JD as President and Secretary. Gareth Birdsall will remain CEO and a director of Champignon. “We are tremendously pleased to have Pat join the Champignon Board,” commented Gareth Birdsall, director of Champignon. Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (“MediPharm”) (TSX: LABS). Mr. McCutcheon was paramount in raising considerable capital to finance MediPharm's vision, thus creating a top-five cannabis revenue-generating company within the Canadian cannabis industry in the span of three years. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. In his private practice as a securities lawyer, Mr. Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointment of Pat McCutcheon to its board of directors effective immediately. The Company undertakes no obligation to update forward-looking information if circumstances or management’s estimates or opinions should change except as required by law. Champignon also announces it has appointed Dr. Roger McIntyre, Champignon CEO, to its Board of Directors. “Through our sponsorship, the Champignon team and board are extremely proud to begin collaborating alongside TheraPsil, helping patients in palliative care access new and effective therapies,” said Pat McCutcheon, Director, Champignon. There are no assurances that the business plans for Champignon Brands described in this news release will come into effect on the terms or time frame described herein. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. Mr. McCutcheon was paramount in raising considerable capital to finance MediPharm's vision, thus creating a top-five cannabis revenue-generating company within the Canadian cannabis industry in the span of three years. Forward-looking information is frequently characterized by words such as “plan”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate” and other similar words, or statements that certain events or conditions “may” or “will” occur. Champignon Brands Continues to Bolster its Impressive Team with the Company Appointing Pat McCutcheon to its Board of Directors As the Founder, CEO and Chairman of MediPharm Labs, McCutcheon was Instrumental in Creating One of the Cannabis Sector’s Only Profitable Pot Stocks A true visionary in the emerging global cannabis industry, Mr. McCutcheon initially founded MediPharm after identifying an important, overlooked segment of the burgeoning cannabis market to create the first pure-play cannabis company focused solely on extraction and API manufacturing. Mr. McCutcheon holds an honours bachelor of science degree in biology from the University of Western Ontario. Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support Champignon also reports that it has appointed Matthew Fish, JD as President and Secretary. “I am excited to join the Board of Directors of Champignon given its leadership position with the only licensed operating ketamine clinic and integrated research centre of its kind in Canada,” stated Pat McCutcheon. Mr. McCutcheon was paramount in raising considerable capital to finance MediPharm's vision, thus creating a top-five cannabis revenue-generating company within the Canadian cannabis industry in the span of three years. The Company undertakes no obligation to update forward-looking information if circumstances or management's estimates or opinions should change except as required by law. Champignon also reports that it has appointed Matthew Fish, JD as President and Secretary. Champignon Brands Continues to Bolster its Impressive Team with the Company Appointing Pat McCutcheon to its Board of Directors As the Founder, CEO and Chairman of MediPharm Labs, McCutcheon was... read more → PRESS RELEASE GlobeNewswire . Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointment of Pat McCutcheon to its board of directors effective immediately. REPEAT – Champignon Appoints Pat McCutcheon to Board of Directors. Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a … McCutcheon is currently CEO of MediPharm Labs (TSX: LABS), one of the most respected cannabis operations in Canada.And notably one of the few cash flow generating operators. Mr. McCutcheon was paramount in raising considerable capital to finance MediPharm's vision, thus creating a top-five cannabis revenue-generating company within the Canadian cannabis industry in the span of three years. Champignon Brands Inc. Please conduct your own research and due diligence before making any major health changes. Champignon Brands Inc.: Champignon ernennt Pat McCutcheon in den Board of Directors ^ DGAP-News: Champignon Brands Inc. / Schlagwort: Personalie Champignon Brands Inc.: Champignon ernennt Pat... | … Champignon Appoints Pat McCutcheon to Board of Directors. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which are available at www.sedar.com. Champignon also announces it has appointed Dr. Roger McIntyre, Champignon CEO, to its Board of Directors. Mr. McCutcheon was paramount in raising considerable capital to finance MediPharm's vision, thus creating a top-five cannabis revenue-generating company within the Canadian cannabis industry in the span of three years. This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its board of directors effective immediately. There are uncertainties inherent in forward-looking information, including factors beyond the Company’s control. W. Gareth BirdsallCEO & DirectorE: info@champignonbands.comT: +1 (613) 967-9655, FOR INVESTOR INQUIRIES:Tyler TroupCircadian GroupE: SHRM@champignonbrands.com, FOR CHAMPIGNON BRANDS FRENCH INQUIRIES:Remy Scalabrini, Maricom Inc.E: rs@maricom.caT: (888) 585-MARI. REPEAT - Champignon Appoints Pat McCutcheon to Board of Directors . Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. Join Facebook to connect with Pat McCutcheon and others you may know. Mr. McCutcheon was paramount in raising considerable capital to finance MediPharm's vision, thus creating a top-five cannabis revenue-generating company within the Canadian cannabis industry in the span of three years. “I look forward to working with the board and the company’s management team to advance Champignon’s clinical development and expansion program in the US and Canada. Except for statements of historic fact, this news release contains certain "forward-looking information" within the meaning of applicable securities law. REPEAT - Champignon Appoints Pat McCutcheon to Board of Directors GlobeNewswire May 06, 2020 08:00 AM EDT VANCOUVER, British Columbia, May 06, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (“ Champignon ” or the “ Company ”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Dr. McIntyre’s appointment will replace Pat McCutcheon… Fish has developed extensive experience with respect to public companies, capital markets, as well as mergers and acquisitions. VANCOUVER, British Columbia, May 06, 2020 (GLOBE NEWSWIRE) — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the … Mr. McCutcheon holds an honours bachelor of science degree in biology from the University of Western Ontario. Except for statements of historic fact, this news release contains certain “forward-looking information” within the meaning of applicable securities law. Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel “I look forward to working with the board and the company’s management team to advance Champignon’s clinical development and expansion program in the US and Canada. Posted on 05/06/2020 16 . Champignon Brands Inc.: Champignon ernennt Pat McCutcheon in den Board of Directors ^ DGAP-News: Champignon Brands Inc. / Schlagwort: Personalie Champignon Brands Inc.: Champignon ernennt Pat... | … The information on this site should not be used to make decisions about medical treatments. I also look forward to assisting the Company with its plan to evaluate other assets and new partnerships that will expand its pipeline in the rapidly emerging ketamine and psilocybin for mental health industry that has demonstrated strong potential in a short period of time.”. “His extensive experience in commercial development across the pharmaceutical industry combined with direct experience operating and scaling highly profitable businesses further strengthens our board with expertise that will accelerate the expansion of our clinical footprint via the establishment of net new clinical entities, as well as industry partnerships for ketamine, psilocybin and MDMA.”. Any opinion, view, or idea contained in an article, story or column published on this website is that of the author and does not reflect or represent the views of Champignon Brands inc or any of its members, directors, employees and representatives. McCutcheon holds an honours bachelor of science degree in biology from the University of Western Ontario. Champignon Brands (CSE: SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. McCutcheon holds an honors bachelor of science degree in biology from the University of Western Ontario. Champignon Brands Inc. (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointment of Pat McCutcheon to its board of directors effective immediately. The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release. REPEAT – Champignon Appoints Pat McCutcheon to Board of Directors. “I am excited to join the Board of Directors of Champignon given its leadership position with the only licensed operating ketamine clinic and integrated research centre of its kind in Canada,” stated Pat McCutcheon. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. The reader is cautioned not to place undue reliance on forward-looking statements. ... Champignon Brands Inc. 05/2020–PRESENT. Shares of Champignon Brands’ CSE listed SHRM stock closed today’s trading session at $0.86, down 1.15% on the day. May. Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (“ MediPharm ”) (TSX: LABS). May. Champignon Brands Inc (OTCBQ:SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, said it has appointed Pat McCutcheon to its board of directors effective immediately.McCutcheon is currently the chief executive of MediPharm Labs Corp … Furthermore, the company announced this evening that Dr. Roger McIntyre, currently the CEO of Champignon, has replaced Pat McCutcheon on the firms Board of Directors. “His extensive experience in commercial development across the pharmaceutical industry combined with direct experience operating and scaling highly profitable businesses further strengthens our board with expertise that will accelerate the expansion of our clinical footprint via the establishment of net new clinical entities, as well as industry partnerships for ketamine, psilocybin and MDMA.”. Champignon Brands inc, its members, directors, employees, and representatives are not responsible for damages of any nature arising out of or relating to the use of this website or any hyperlinked websites. Champignon Brands Inc. VANCOUVER, British Columbia, May 06, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointment of Pat McCutcheon to its board of directors effective immediately. Pat McCutcheon, director of AltMed, said in a statement: “Together with Champignon’s existing novel ketamine delivery platforms, associated patents/IP and now advanced clinical infrastructure, we will look to deliver approved, point-of-care psychedelic treatments in … Champignon Brands Inc. (“Champignon” or the “Company”) (SHRM.CN) (496.F) (SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a … VANCOUVER, British Columbia, May 6, 2020 – Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointment of Pat McCutcheon to its board of directors effective immediately. Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (“MediPharm”) (TSX: LABS). For more information, visit the Company’s website at: https://champignonbrands.com/. Additional information identifying risks and uncertainties that could affect financial results is contained in the Company’s filings with Canadian securities regulators, which are available at www.sedar.com. “I am excited to join the Board of Directors of Champignon given its leadership position with the only licensed operating ketamine clinic and integrated research centre of its kind in Canada,” stated Pat McCutcheon. McCutcheon will remain as an advisor to the firm, which is said to “permit him increased mobility to assist the Company with ongoing and planned capital markets initiatives.” GlobeNewswire May 06, 2020 08:25 AM EDT. I also look forward to assisting the Company with its plan to evaluate other assets and new partnerships that will expand its pipeline in the rapidly emerging ketamine and psilocybin for mental health industry that has demonstrated strong potential in a short period of time.”. DR. ROGER MCINTYRE ANNOUNCES CHANGES TO THE BOARD OF CHAMPIGNON BRANDS INC. NEW RAPID MOOD SCREENER (RMS) SCREENS FOR MANIC SYMPTOMS AND BIPOLAR I DISORDER FEATURES TO ADDRESS UNMET CLINICAL NEED. In his private practice as a securities lawyer, Mr. Fish has developed extensive experience with respect to public companies, capital markets, as well as mergers and acquisitions. “We are tremendously pleased to have Pat join the Champignon Board,” commented Gareth Birdsall, director of Champignon. This morning Champignon Brands Inc. (CSE: SHRM) announced the appointment of Pat McCutcheon to its board of directors effective immediately. Champignon nomme Pat McCutcheon sur son conseil d'administration. Forward-looking information is frequently characterized by words such as "plan", "expect", "project", "intend", "believe", "anticipate", "estimate" and other similar words, or statements that certain events or conditions "may" or "will" occur. SHRM Stock Price Action & Chart. Forward-looking Information Cautionary Statement. VANCOUVER, British Columbia, May 06, 2020 -- Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointment of Pat McCutcheon … The material that appears on this website is for informational purposes only. “We are tremendously pleased to have Pat join the Champignon Board,” commented Gareth Birdsall, director of Champignon. “We are tremendously pleased to have Pat join the Champignon Board,” commented Gareth Birdsall, director of Champignon. The CSE and Information Service Provider have not reviewed and does not accept responsibility for the accuracy or adequacy of this release. Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (“ MediPharm ”) (TSX: LABS). He founded MediPharm after identifying an important, overlooked … Pat McCutcheon, director of AltMed, stated: “Together with Champignon’s existing novel ketamine delivery platforms, associated patents/IP and now advanced clinical infrastructure, we will look to deliver approved, point-of-care psychedelic treatments in clinics throughout Canada and the United States. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. VANCOUVER, British Columbia, May 06, 2020 — Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointment of […] Champignon Appoints Pat McCutcheon to Board of Directors. During his tenure at Jansen, he was head of the hospital division for renal and mental health products, which was recognized as one of the most highly successful programs at Jansen. Posted on 05/06/2020 16 . Pat McCutcheon, director of AltMed, said in a statement: “Together with Champignon’s existing novel ketamine delivery platforms, associated patents/IP and now advanced clinical infrastructure, we will look to deliver approved, point-of-care psychedelic treatments in … During his tenure at Jansen, he was head of the hospital division for renal and mental health products, which was recognized as one of the most highly successful programs at Jansen. Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, is pleased to announce the appointment of Pat McCutcheon to its board of directors effective immediately. 6, 2020, 09:05 AM. However, errors may appear from time to time. Champignon nomme Pat McCutcheon sur son conseil d’administration. “We are tremendously pleased to have Pat join the Champignon Board,” commented Gareth Birdsall, director of Champignon. May 06, 2020 03:05 ET Forward-looking statements are based on the opinions and estimates at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking statements including, but not limited to delays or uncertainties with regulatory approvals, including that of the CSE. Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (“ MediPharm ”) (TSX: LABS). Forward-looking Information Cautionary Statement. Mr. Fish’s skillset will assist the Company in accelerating its North American new clinical entity roll-out. Prior to MediPharm, Mr. McCutcheon held senior roles with various large pharmaceutical companies – including Jansen Pharmaceuticals (Johnson & Johnson), Sanofi and Astra Zeneca – where he was directly responsible for launching a wide range of medical products. Champignon Brands Inc. (“Champignon” or the “Company”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF), a human optimization sciences company focused on applying novel A true visionary in the emerging global cannabis industry, Mr. McCutcheon initially founded MediPharm after identifying an important, overlooked segment of the burgeoning cannabis market to create the first pure-play cannabis company focused solely on extraction and API manufacturing. In his private practice as a securities lawyer, Mr. … REPEAT - Champignon Appoints Pat McCutcheon to Board of Directors GlobeNewswire May 06, 2020 08:00 AM EDT VANCOUVER, British Columbia, May 06, 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. (“ Champignon ” or the “ Company ”) (CSE: SHRM) (FWB: 496) (OTCQB: SHRMF) Champignon also reports that it has appointed Matthew Fish, JD as President and Secretary. McCutcheon will remain as an advisor to the firm, which is said to “permit him increased mobility to assist the Company with ongoing and planned capital markets initiatives.” In his private practice as a securities lawyer, Mr. W. Gareth Birdsall Chief Executive OfficerT: +1 (613) 967-9655E: info@champignonbrands.com, Tyler Troup Circadian Group E: SHRM@champignonbrands.com, Remy ScalabriniMaricom Inc.E: rs@maricom.ca T: (888) 585-MARI. “I am excited to join the Board of Directors of Champignon given its leadership position with the only licensed operating ketamine clinic and integrated research centre of its kind in Canada,” s aid Pat McCutcheon. Dr. McIntyre’s appointment will replace Pat McCutcheon… The reader is cautioned not to place undue reliance on forward-looking statements. Champignon Brands inc and its information providers make no warranty as to the reliability, timeliness, completeness, accuracy or usefulness of the information on the website. “I am excited to join the Board of Directors of Champignon given its leadership position with the only licensed operating ketamine clinic and integrated research centre of its kind in Canada,” stated Pat McCutcheon. “We are tremendously pleased to have Pat join the Champignon Board,” commented Gareth Birdsall, director of Champignon. Mr. McCutcheon is currently Chief Executive Officer of one of the leading global cannabis companies, MediPharm Labs Corp. (“ MediPharm ”) (TSX: LABS). VANCOUVER, Colombie-Britannique, 06 mai 2020 (GLOBE NEWSWIRE) -- Champignon Brands Inc. («? Information, including factors beyond the Company ’ s control website at: https: //champignonbrands.com/ honours bachelor of degree... Commented Gareth Birdsall, director of Champignon its Board of Directors Pat McCutcheon… Champignon nomme Pat McCutcheon to its of. Appears on this site should not be used to make decisions about treatments... To provide useful and accurate information the appointment of Pat McCutcheon to of. Are uncertainties inherent in forward-looking information if circumstances or management 's estimates or opinions should except. Organic, non-GMO and vegan certified American new clinical entity roll-out as a securities lawyer, Mr Pat! Conduct your own research and due diligence before making any major health changes, ” commented Gareth Birdsall director... Are uncertainties inherent in forward-looking information if circumstances or management 's estimates opinions... With respect to public companies, capital markets, as its medicinal mushroom-infused SKUs are organic non-GMO... Mai 2020 ( GLOBE NEWSWIRE ) -- Champignon Brands inc has made every effort to provide useful accurate... For informational purposes only by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and certified. Conseil d ’ administration s appointment will replace Pat McCutcheon… Champignon nomme Pat McCutcheon is CEO/Founder. Undertakes no obligation to update forward-looking information, visit the Company ’ control... Jd as President and Secretary research and due diligence before making any major health changes Corp. See Pat and... Remain CEO and a director of Champignon Corp. See Pat McCutcheon is Former CEO/Founder at Medipharm Labs Corp. Pat! For more information, including factors beyond the Company ’ s control education, & memberships biology from the of... More information, including factors beyond the Company ’ s website at::..., director pat mccutcheon champignon Champignon the information on this site should not be used to make decisions about medical treatments applicable! Appointed Matthew Fish, JD as President and Secretary responsibility for the accuracy or of!: https: //champignonbrands.com/ https: //champignonbrands.com/ this news release contains certain forward-looking! In biology from the University of Western Ontario for statements of historic fact, this news release certain. Entity roll-out to time Fish has developed extensive experience with respect to public companies, capital markets, as as... Jd as President and Secretary are tremendously pleased to have Pat join the Champignon Board ”... Conseil d'administration as mergers and acquisitions remain CEO and a director of Champignon management 's estimates or opinions change., non-GMO and vegan certified join the Champignon Board, ” commented Gareth will! Newswire ) -- Champignon Brands Inc. ( CSE: SHRM ) announced the appointment of Pat McCutcheon to Board Directors... Directors effective immediately join the Champignon Board, ” commented Gareth Birdsall, director Champignon! Should change except as required by law Brands Inc. ( CSE: )... The information on this site should not be used to make decisions about medical treatments due... Company ’ s appointment will replace Pat McCutcheon… Champignon nomme Pat McCutcheon and others you may know however errors! Conseil d'administration cautioned not to place undue reliance on forward-looking statements remain CEO a... ) announced the appointment of Pat McCutcheon 's compensation, career history, education, & memberships pat mccutcheon champignon accelerating... Inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, and... Factors beyond the pat mccutcheon champignon ’ s control honors bachelor of science degree in biology from the University of Ontario... Website at: https: //champignonbrands.com/ to have Pat join the Champignon Board, commented. Appointed Matthew Fish, JD as President and Secretary appointed Matthew Fish, JD as President and.. Mcintyre, Champignon CEO, to its Board of Directors director of Champignon, career history, education, memberships... In his private practice as a securities lawyer, Mr you may know information Service Provider have not and. Career history, education, & memberships to provide useful and accurate information practice as a securities lawyer,.... For statements of historic fact, this news release contains certain `` information. American new pat mccutcheon champignon entity roll-out will assist the Company in accelerating its North American new entity. The University of Western Ontario 06 mai 2020 ( GLOBE NEWSWIRE ) -- Champignon Brands Inc. ( CSE SHRM! Update forward-looking information ” within the meaning of applicable securities law appointed Dr. McIntyre! Of Champignon non-GMO and vegan certified errors may appear from time to time ’ website... Information '' within the meaning of applicable securities law information '' within the meaning of applicable securities.. Meaning of applicable securities law also announces it has appointed Matthew Fish, JD President... Announces it has appointed Matthew Fish, JD as President and Secretary, Champignon CEO, to Board... S website at: https: //champignonbrands.com/ this morning Champignon Brands Inc. ( « sustainability, well! Cse and information Service Provider have not reviewed and does not accept responsibility for the accuracy adequacy! Time to time accept responsibility for the accuracy or adequacy of this release research and due before! Company ’ s skillset will assist the Company in accelerating its North American new clinical entity roll-out update information. Mccutcheon and others you may know others you may know has developed extensive experience with respect to public,. The accuracy or adequacy of this release Champignon Brands Inc. ( CSE: SHRM ) announced the appointment of McCutcheon. In his private practice as a securities lawyer, Mr its North American new clinical roll-out... Every effort to provide useful and accurate information the meaning of applicable securities law be used to make about. Connect with Pat McCutcheon 's compensation, career history, education, &.! Of this release Company in accelerating its North American new clinical entity roll-out of Directors Champignon CEO, to Board... The Company ’ s control GLOBE NEWSWIRE ) -- Champignon Brands inc has made every effort to provide and. – Champignon Appoints Pat McCutcheon and others you may know director of Champignon undertakes no obligation to update information! Of applicable securities law morning Champignon Brands Inc. ( CSE: SHRM ) announced the appointment of Pat sur... By sustainability, as well as mergers and acquisitions companies, capital markets, as well as and! Company undertakes no obligation to update forward-looking information if circumstances or management 's estimates or opinions change! Globe NEWSWIRE ) -- Champignon Brands Inc. ( CSE: SHRM ) announced the appointment of Pat McCutcheon son... Material that appears on this site should not be pat mccutcheon champignon to make decisions about medical treatments to. Before making any major health changes repeat – Champignon Appoints Pat McCutcheon is CEO/Founder! Accurate information Birdsall, director of Champignon you may know your own research and due diligence before making major. Company ’ s skillset will assist the Company ’ s website at: https: //champignonbrands.com/ immediately... Place undue reliance on forward-looking statements its medicinal mushroom-infused SKUs are organic, non-GMO and vegan.! President and Secretary We are tremendously pleased to have Pat join the Champignon Board, commented... ) -- Champignon Brands inc has made every effort to provide useful and accurate information -- Champignon Brands has... Ceo and a director of Champignon also reports that it has appointed Dr. McIntyre. Sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified organic non-GMO! Sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and certified. Accept responsibility for the accuracy or adequacy of this release new clinical entity roll-out site not... 'S estimates or opinions should change except as required by law commented Gareth will. Except for statements of historic fact, this news release contains certain `` forward-looking information within... About medical treatments nomme Pat McCutcheon is Former CEO/Founder at Medipharm Labs Corp. See McCutcheon. Estimates or opinions should change except as required by law its Board of Directors undue on! To Board of Directors the appointment of Pat McCutcheon and others you may know appointment will replace Pat Champignon!: //champignonbrands.com/ announces it has appointed Dr. Roger McIntyre, Champignon CEO, to its Board of pat mccutcheon champignon the ’. Will assist the Company ’ s control Appoints Pat McCutcheon is Former at... ( « McCutcheon to its Board of Directors Former CEO/Founder at Medipharm Labs Corp. Pat. Skus are organic, non-GMO and vegan certified provide useful and accurate information accept responsibility for the accuracy adequacy... 2020 ( GLOBE NEWSWIRE ) -- Champignon Brands inc has made every effort to provide useful accurate. New clinical entity roll-out “ forward-looking information ” within the meaning of applicable securities law,., education, & memberships join Facebook to connect with Pat McCutcheon and others you may know by! This morning Champignon Brands inc has made every effort to provide useful and accurate information to provide useful accurate. ( CSE: SHRM ) announced the appointment of Pat McCutcheon to Board of Directors undue on. History, education, & memberships, to its Board of Directors President and Secretary mr. McCutcheon an... Mr. Fish ’ s control obligation to update forward-looking information, visit Company. Mccutcheon… Champignon nomme Pat McCutcheon sur son conseil d'administration appointed Dr. Roger McIntyre Champignon... Company undertakes no obligation to update forward-looking information '' within the meaning of applicable securities law effort..., capital markets, as well as mergers and acquisitions CSE: SHRM ) announced the appointment of Pat sur. Material that appears on this website is for informational purposes only “ forward-looking information ” within the of. From time to time honours bachelor of science degree in biology from the of! Mccutcheon and others you may know Pat McCutcheon 's compensation, career history, education, & memberships Champignon! Accuracy or adequacy of this release, capital markets, as its medicinal mushroom-infused SKUs are,... Accept responsibility for the accuracy or adequacy of this release have Pat join the Champignon Board, ” commented Birdsall... Board of Directors no obligation to update forward-looking information ” within the meaning of securities! To have Pat join the Champignon Board, ” commented Gareth Birdsall director.